(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 5.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Hologic's revenue in 2025 is $4,100,500,000.On average, 22 Wall Street analysts forecast HOLX's revenue for 2026 to be $975,433,277,728, with the lowest HOLX revenue forecast at $926,171,222,340, and the highest HOLX revenue forecast at $1,010,652,303,752. On average, 20 Wall Street analysts forecast HOLX's revenue for 2027 to be $1,028,930,532,448, with the lowest HOLX revenue forecast at $966,071,258,152, and the highest HOLX revenue forecast at $1,070,390,904,856.
In 2028, HOLX is forecast to generate $1,083,988,123,764 in revenue, with the lowest revenue forecast at $1,010,875,208,980 and the highest revenue forecast at $1,137,262,473,256.